Michael Freeman

A potential cancer drug aimed at enhancing the effectiveness of ionizing radiation in lung cancer patients is a step closer to development with funding support from the Small Business Innovation Research program. Read More

To develop strategies for preventing radiation-induced lung fibrosis (scarring), Vanderbilt investigators are exploring the cell types and factors that contribute to the fibrotic response. Read More

New findings identify isoketal-modified proteins as a previously unrecognized feature of pulmonary fibrosis and as a potential therapeutic target for this disease. Read More

A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies. Read More

Antioxidant genes may be good targets for treating a stomach disorder that affects up to 40 percent of patients with diabetes. Read More